Iren [IREN] vs Morgan Stanley [MS] Detailed Stock Comparison
Iren
NASDAQ
Loading...
Morgan Stanley
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Iren wins in 5 metrics, Morgan Stanley wins in 12 metrics, with 0 ties. Morgan Stanley appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Iren | Morgan Stanley | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 3.56 | 16.40 | Iren |
| Price-to-Book Ratio | 2.94 | 2.35 | Morgan Stanley |
| Debt-to-Equity Ratio | 22.73 | 438.54 | Iren |
| PEG Ratio | -0.04 | 1.01 | Iren |
| EV/EBITDA | 39.77 | N/A | N/A |
| Profit Margin (TTM) | -9.44% | 22.49% | Morgan Stanley |
| Operating Margin (TTM) | 18.84% | 34.12% | Morgan Stanley |
| EBITDA Margin (TTM) | 18.84% | 34.12% | Morgan Stanley |
| Return on Equity | -3.39% | 14.13% | Morgan Stanley |
| Return on Assets (TTM) | -0.68% | 1.16% | Morgan Stanley |
| Free Cash Flow (TTM) | $-610.78M | $-2.10B | Iren |
| Dividend Yield | N/A | 2.15% | N/A |
| 1-Year Return | 127.26% | 41.37% | Iren |
| Price-to-Sales Ratio (TTM) | 11.99 | 3.52 | Morgan Stanley |
| Enterprise Value | $5.15B | $158.15B | Morgan Stanley |
| EV/Revenue Ratio | 13.62 | 2.41 | Morgan Stanley |
| Gross Profit Margin (TTM) | 94.85% | N/A | N/A |
| Revenue per Share (TTM) | $2 | $41 | Morgan Stanley |
| Earnings per Share (Diluted) | $-0.31 | $8.83 | Morgan Stanley |
| Beta (Stock Volatility) | 3.99 | 1.32 | Morgan Stanley |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Iren vs Morgan Stanley Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Iren | 9.37% | 2.67% | 7.93% | 120.36% | 80.06% | 87.28% |
| Morgan Stanley | -0.06% | -3.01% | 2.54% | 14.96% | 9.38% | 15.44% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Iren | 127.26% | 305.59% | -21.01% | -21.01% | -21.01% | -21.01% |
| Morgan Stanley | 41.37% | 65.93% | 172.34% | 323.02% | 475.47% | 179.36% |
Performance & Financial Health Analysis: Iren vs Morgan Stanley
| Metric | IREN | MS |
|---|---|---|
| Market Information | ||
| Market Cap | $4.53B | $231.12B |
| Market Cap Category | Mid cap | Mega cap |
| 10 Day Avg. Volume | 22,350,126 | 4,617,060 |
| 90 Day Avg. Volume | 25,511,285 | 5,290,947 |
| Last Close | $21.42 | $144.04 |
| 52 Week Range | $5.12 - $21.72 | $94.09 - $149.08 |
| % from 52W High | -1.36% | -3.38% |
| All-Time High | $28.25 (Nov 15, 2021) | $148.81 (Aug 15, 2025) |
| % from All-Time High | -24.18% | -3.21% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 1.73% | 0.11% |
| Quarterly Earnings Growth | 1.81% | 0.15% |
| Financial Health | ||
| Profit Margin (TTM) | -0.09% | 0.22% |
| Operating Margin (TTM) | 0.19% | 0.34% |
| Return on Equity (TTM) | -0.03% | 0.14% |
| Debt to Equity (MRQ) | 22.73 | 438.54 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $6.38 | $61.59 |
| Cash per Share (MRQ) | $0.76 | $352.68 |
| Operating Cash Flow (TTM) | $-210,571,008 | $-17,670,000,640 |
| Levered Free Cash Flow (TTM) | $-990,652,480 | $12.80B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 2.15% |
| Last 12-Month Dividend | N/A | $2.79 |
Valuation & Enterprise Metrics Analysis: Iren vs Morgan Stanley
| Metric | IREN | MS |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 3.56 | 16.40 |
| Forward P/E | 55.09 | 18.26 |
| PEG Ratio | -0.04 | 1.01 |
| Price to Sales (TTM) | 11.99 | 3.52 |
| Price to Book (MRQ) | 2.94 | 2.35 |
| Market Capitalization | ||
| Market Capitalization | $4.53B | $231.12B |
| Enterprise Value | $5.15B | $158.15B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 13.62 | 2.41 |
| Enterprise to EBITDA | 39.77 | N/A |
| Risk & Other Metrics | ||
| Beta | 3.99 | 1.32 |
| Book Value per Share (MRQ) | $6.38 | $61.59 |
Financial Statements Comparison: Iren vs Morgan Stanley
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | IREN | MS |
|---|---|---|
| Revenue/Sales | $144.82M | $16.52B |
| Cost of Goods Sold | $7.46M | N/A |
| Gross Profit | $137.36M | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $24.62M | N/A |
| EBITDA | $77.27M | N/A |
| Pre-Tax Income | $29.27M | $5.54B |
| Income Tax | $5.04M | $1.17B |
| Net Income (Profit) | $24.23M | $4.37B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | IREN | MS |
|---|---|---|
| Cash & Equivalents | $184.33M | $60.84B |
| Total Current Assets | $255.91M | N/A |
| Total Current Liabilities | $553.11M | N/A |
| Long-Term Debt | $1.23M | $303.93B |
| Total Shareholders Equity | $1.43B | $107.85B |
| Retained Earnings | $-691.84M | $107.65B |
| Property, Plant & Equipment | $948.97M | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | IREN | MS |
|---|---|---|
| Operating Cash Flow | N/A | $-67.29B |
| Capital Expenditures | $-442.15M | $-713.00M |
| Free Cash Flow | $-491.82M | $-24.69B |
| Debt Repayment | $-126,000 | $-20.85B |
| Common Stock Repurchase | N/A | $-2.03B |
Short Interest & Institutional Ownership Analysis
| Metric | IREN | MS |
|---|---|---|
| Shares Short | 26.86M | 14.60M |
| Short Ratio | 0.85 | 2.55 |
| Short % of Float | 0.12% | 0.01% |
| Average Daily Volume (10 Day) | 22,350,126 | 4,617,060 |
| Average Daily Volume (90 Day) | 25,511,285 | 5,290,947 |
| Shares Outstanding | 186.37M | 1.61B |
| Float Shares | 198.26M | 1.21B |
| % Held by Insiders | 0.06% | 0.24% |
| % Held by Institutions | 0.71% | 0.63% |
Dividend Analysis & Yield Comparison: Iren vs Morgan Stanley
| Metric | IREN | MS |
|---|---|---|
| Last 12-Month Dividend | N/A | $2.79 |
| Last 12-Month Dividend Yield | N/A | 2.15% |
| 3-Year Avg Annual Dividend | N/A | $3.10 |
| 3-Year Avg Dividend Yield | N/A | 0.90% |
| 3-Year Total Dividends | N/A | $9.31 |
| Ex-Dividend Date | N/A | Jan 31, 2025 |